eISSN: 2450-5722
ISSN: 2450-5927
Journal of Health Inequalities
Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2020
vol. 6
 
Share:
Share:
abstract:
Special paper

History of smoking cessation treatment in Poland – the strengthening role of cytisine as the most effective and safe pharmacotherapy

Witold A. Zatoński
1, 2
,
Kinga Janik-Koncewicz
1, 2
,
Zuzanna Stępnicka
3
,
Katarzyna Zatońska
3
,
Katarzyna Połtyn-Zaradna
3
,
Aleksandra Herbeć
2, 4

  1. Institute – European Observatory of Health Inequalities, Calisia University, Kalisz, Poland
  2. Health Promotion Foundation, Nadarzyn, Poland
  3. Department of Social Medicine, Wroclaw Medical University, Poland
  4. University College London, United Kingdom
J Health Inequal 2020; 6 (2): 116-123
Online publish date: 2020/12/30
View full text Get citation
 
PlumX metrics:
One of the greatest public health successes in Poland since the 1990s has been a decline in tobacco-related morbidity and mortality, including from lung cancer and cardiovascular disease. The steady decline in smoking cigarettes among adults in Poland during this period was among the most important factors contributing to this success. The key enabling factor in this process was the increasing range and availability of different pharmacotherapy supporting smoking cessation, including nicotine replacement therapy, but especially of the safe and affordable cytisine. The popularity of cytisine has been continuously growing among smokers in Poland. New developments in cytisine-based treatments and research in Poland and abroad can further strengthen global tobacco control efforts. Cytisine requires much greater interest from the medical community and from those responsible for public health in Poland.
keywords:

smoking cessation, cytisine, varenicline, nicotine replacement therapy, Poland


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.